Log in

Allied Minds Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $0.55
50-Day Range
MA: $0.53
52-Week Range
Now: $0.55
Average Volume4,170 shs
Market Capitalization$133.35 million
P/E RatioN/A
Dividend YieldN/A
Allied Minds plc is a private equity and venture capital firm specializing in pre-seed, seed, start-up, and early stage technology investments. The firm prefers to invest across all products, services, and industries with a focus on the life science and technology sector including medical devices, diagnostics, biopharmaceuticals, big data, cyber security, communications, semiconductors, and food safety. It primarily invests in companies based in the United States, but depending on opportunities this could be expanded to a global network of partners and investments. The firm typically invests between $0.25 million and $1 million in seed investments and from $5 million to $10 million in Series A investments. The firm focuses on commercializing technologies from leading United States Universities and national labs. It seeks to take majority equity positions in its portfolio companies. The firm partners with universities to fund licensing deals and corporate spin-outs. It prefers to continue to invest alongside a syndicate for larger Series A and follow-on rounds. Allied Minds plc is based in Boston, Massachusetts with additional offices in London, United Kingdom; Los Angeles, California; Seattle, Washington; New York; New York and Washington, DC.
Read More
Allied Minds logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.44 out of 5 stars

Industry, Sector and Symbol

Industry Investors, not elsewhere classified
Previous SymbolNASDAQ:ALLWF



Sales & Book Value

Annual SalesN/A



Market Cap$133.35 million
Next Earnings DateN/A
OptionableNot Optionable
0.00 (0.00 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALLWF News and Ratings via Email

Sign-up to receive the latest news and ratings for ALLWF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Allied Minds (OTCMKTS:ALLWF) Frequently Asked Questions

How has Allied Minds' stock been impacted by Coronavirus?

Allied Minds' stock was trading at $0.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ALLWF shares have increased by 25.5% and is now trading at $0.5520.
View which stocks have been most impacted by COVID-19

Who are some of Allied Minds' key competitors?

Who are Allied Minds' key executives?

Allied Minds' management team includes the following people:
  • Ms. Jill Deborah Smith, Pres, CEO & Exec. Director (Age 61)
  • Mr. Joseph A. Pignato CPA, Chief Financial Officer (Age 51)
  • Mr. Mark Biagini, Director of Information Technology
  • Mr. Michael S. Turner J.D., Gen. Counsel & Company Sec. (Age 52)
  • Mr. Neil Pizey, Head of Corp. Devel.

What is Allied Minds' stock symbol?

Allied Minds trades on the OTCMKTS under the ticker symbol "ALLWF."

How do I buy shares of Allied Minds?

Shares of ALLWF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Allied Minds' stock price today?

One share of ALLWF stock can currently be purchased for approximately $0.55.

How big of a company is Allied Minds?

Allied Minds has a market capitalization of $133.35 million.

What is Allied Minds' official website?

The official website for Allied Minds is www.alliedminds.com.

How can I contact Allied Minds?

Allied Minds' mailing address is 100 High Street 28th Floor, Boston MA, 02110. The company can be reached via phone at 617-419-1800 or via email at [email protected]

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.